chr10-114300356-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001001936.3(AFAP1L2):c.1795G>A(p.Glu599Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000088 in 1,614,052 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001001936.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AFAP1L2 | NM_001001936.3 | c.1795G>A | p.Glu599Lys | missense_variant | 15/19 | ENST00000304129.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AFAP1L2 | ENST00000304129.9 | c.1795G>A | p.Glu599Lys | missense_variant | 15/19 | 1 | NM_001001936.3 | P4 | |
AFAP1L2 | ENST00000369271.7 | c.1795G>A | p.Glu599Lys | missense_variant | 15/19 | 1 | A2 | ||
AFAP1L2 | ENST00000696688.1 | c.1879G>A | p.Glu627Lys | missense_variant | 16/20 | A2 | |||
AFAP1L2 | ENST00000491814.1 | n.917G>A | non_coding_transcript_exon_variant | 3/6 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152206Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251402Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135864
GnomAD4 exome AF: 0.0000896 AC: 131AN: 1461846Hom.: 0 Cov.: 30 AF XY: 0.0000770 AC XY: 56AN XY: 727218
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152206Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 11, 2023 | The c.1795G>A (p.E599K) alteration is located in exon 15 (coding exon 15) of the AFAP1L2 gene. This alteration results from a G to A substitution at nucleotide position 1795, causing the glutamic acid (E) at amino acid position 599 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at